JP2023500011A5 - - Google Patents

Info

Publication number
JP2023500011A5
JP2023500011A5 JP2022507566A JP2022507566A JP2023500011A5 JP 2023500011 A5 JP2023500011 A5 JP 2023500011A5 JP 2022507566 A JP2022507566 A JP 2022507566A JP 2022507566 A JP2022507566 A JP 2022507566A JP 2023500011 A5 JP2023500011 A5 JP 2023500011A5
Authority
JP
Japan
Application number
JP2022507566A
Other languages
Japanese (ja)
Other versions
JP2023500011A (ja
JPWO2021028299A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/072087 external-priority patent/WO2021028299A1/en
Publication of JP2023500011A publication Critical patent/JP2023500011A/ja
Publication of JPWO2021028299A5 publication Critical patent/JPWO2021028299A5/ja
Publication of JP2023500011A5 publication Critical patent/JP2023500011A5/ja
Withdrawn legal-status Critical Current

Links

JP2022507566A 2019-08-12 2020-08-06 遺伝子療法によるパーキンソン病などのシヌクレイノパチーの治療に使用するためのウイルス粒子 Withdrawn JP2023500011A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19382706.0 2019-08-12
EP19382706 2019-08-12
PCT/EP2020/072087 WO2021028299A1 (en) 2019-08-12 2020-08-06 Viral particles for use in treating synucleinopathies such as parkinson's diseases by gene therapy

Publications (3)

Publication Number Publication Date
JP2023500011A JP2023500011A (ja) 2023-01-04
JPWO2021028299A5 JPWO2021028299A5 (https=) 2023-08-08
JP2023500011A5 true JP2023500011A5 (https=) 2023-08-08

Family

ID=67659024

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022507566A Withdrawn JP2023500011A (ja) 2019-08-12 2020-08-06 遺伝子療法によるパーキンソン病などのシヌクレイノパチーの治療に使用するためのウイルス粒子

Country Status (18)

Country Link
US (1) US20220298528A1 (https=)
EP (1) EP4013437A1 (https=)
JP (1) JP2023500011A (https=)
KR (1) KR20220099944A (https=)
CN (1) CN114786694A (https=)
AR (1) AR119609A1 (https=)
AU (1) AU2020328827A1 (https=)
BR (1) BR112022002615A2 (https=)
CA (1) CA3149844A1 (https=)
CL (1) CL2022000292A1 (https=)
CO (1) CO2022001192A2 (https=)
EC (1) ECSP22008949A (https=)
IL (1) IL290357A (https=)
MX (1) MX2022001676A (https=)
PE (1) PE20220601A1 (https=)
PH (1) PH12022550282A1 (https=)
TW (1) TW202120687A (https=)
WO (1) WO2021028299A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112021015312A2 (pt) 2019-02-04 2021-11-09 Freeline Therapeutics Ltd Polinucleotídeos, partícula viral e composição
EP4192961A2 (en) * 2020-08-06 2023-06-14 Fundacion para la Investigacion Medica Aplicada Viral particles for use in treating tauopathies such as alzheimer's diseases by gene therapy
WO2023202637A1 (en) * 2022-04-19 2023-10-26 Shanghai Vitalgen Biopharma Co., Ltd. Recombinant aav vectors for treating neurodegenerative disorders
WO2024074142A1 (en) * 2022-10-08 2024-04-11 Lingyi Biotech Co., Ltd. Polynucleotides for the treatment of disease associated with gcase deficiency
WO2025063407A1 (ko) * 2023-09-22 2025-03-27 주식회사 스탠드업테라퓨티스 신규한 파킨슨 병 치료제

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3292206B8 (en) * 2015-05-07 2022-02-09 Takeda Pharmaceutical Company Limited Glucocerebrosidase gene therapy for parkinson's disease
EP3692075A4 (en) * 2017-10-03 2022-02-09 Prevail Therapeutics, Inc. GENE THERAPIES FOR LYSOSOMAL DISEASES
WO2019068854A1 (en) * 2017-10-06 2019-04-11 Ospedale San Raffaele S.R.L. GENE THERAPY OF NEURODEGENERATIVE DISEASES USING VAA VECTORS

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
JP2023500011A5 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)